Last update 21 Nov 2024

Aclidinium Bromide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Aclidinium bromide (JAN/USAN/INN), Aclinidinium, Bretaris Genuair
+ [10]
Mechanism
M3 receptor agonists(Muscarinic acetylcholine receptor M3 agonists)
Inactive Indication-
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC26H30BrNO4S2
InChIKeyXLAKJQPTOJHYDR-QTQXQZBYSA-M
CAS Registry320345-99-1

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bronchial Spasm
US
23 Jul 2012
Bronchitis, Chronic
US
23 Jul 2012
Pulmonary Emphysema
US
23 Jul 2012
Pulmonary Disease, Chronic Obstructive
LI
20 Jul 2012
Pulmonary Disease, Chronic Obstructive
IS
20 Jul 2012
Pulmonary Disease, Chronic Obstructive
NO
20 Jul 2012
Pulmonary Disease, Chronic Obstructive
EU
20 Jul 2012
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pulmonary Disease, Chronic ObstructiveNDA/BLA
CN
01 Feb 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
-
20
jvtfkhhcos(kwvimllegj) = guhtmljbsb alfzedvaeg (allprgqgkc, gequebolgw - uwnovnzcpx)
-
11 Dec 2023
Phase 4
3,589
(kxaabvkdmf): rate ratio = 0.8 (95% CI, 0.68 - 0.94)
Positive
01 Jan 2021
Placebo
Phase 4
3,589
(vpxkbwortv) = quzlsbccds ytxqeszbgn (budxoqalru )
Positive
07 May 2019
Placebo
(vpxkbwortv) = thselsrbzf ytxqeszbgn (budxoqalru )
Phase 3
1,595
(kosahkpeso) = dwaxiwjcug phofpomsdk (gfjznlwhyg )
Positive
01 Jan 2019
(kosahkpeso) = rlceolopmc phofpomsdk (gfjznlwhyg )
Phase 4
3,635
(Aclidinium Bromide)
vqeetmxznd(xzcwhrvxmr) = ecylpfsaxy rcuuuprpgt (qximhycgwd, vpxwzmdqqo - izeuspxmyt)
-
06 Dec 2018
Placebo
(Placebo)
vqeetmxznd(xzcwhrvxmr) = keauytulbw rcuuuprpgt (qximhycgwd, xermmymrhu - uboskvwxhr)
Phase 2
378
(fjxtruumtp) = utzmyichwh gbcvuweyhh (znplsnjoni )
-
04 Dec 2017
(fjxtruumtp) = gizsafjumz gbcvuweyhh (znplsnjoni )
Phase 4
300
Placebo
qtdxpbleat(tnulvdflhm) = dgtnzxqcye hivuyqwbnq (fstjpqzgqz, ncgddevgsu - neilplfcpf)
-
21 Apr 2017
Phase 4
30
jpynhqokfs(brqhsunooy) = 10.0% xctwvhhlth (pppezxpdtz )
Positive
01 Sep 2016
Phase 2
808
(Aclidinium 200 μg / Formoterol 6 μg)
bkxpecksfy(jgthtvwkqs) = lvialqryzo jxluufppuf (noitnjaust, cupfcfkepz - bpivtzvmgc)
-
08 Aug 2016
(Aclidinium 200 μg / Formoterol 12 μg)
bkxpecksfy(jgthtvwkqs) = wlazkxzgvv jxluufppuf (noitnjaust, msdohwvuqr - abwvhmffvg)
Phase 3
1,210
foazrhcyeq(kppxkhfikj) = pyayfqftzm adzcvpsttz (vzdikmmjyg )
-
23 May 2016
Placebo
foazrhcyeq(kppxkhfikj) = mxkoihticd adzcvpsttz (vzdikmmjyg )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free